Alpha Teknova, Inc. (TKNO): Depreciation & Amortization
$6.34M
Year ended 2025-12-31
$6.34M
Trailing 12 months to 2026-06-30
+26.1%
3-year compound annual growth
+25.4%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.34M | -3.6% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $6.58M | +16.2% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $5.66M | +78.8% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $3.17M | +9.8% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $2.88M | +41.0% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $2.04M | n/a | 2022-03-18, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $6.34M | -3.6% |
| Immucell Corp (ICCC) | 2025-12-31 | $2.78M | +2.0% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $9.77M | -5.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $112.0K | +21.7% |
| Biomerica Inc (BMRA) | 2026-05-31 | $77.0K | -11.5% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $2.19M | +48.4% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $53.70M | -12.3% |
| Neogen Corp (NEOG) | 2026-05-31 | $116.30M | -2.7% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $983.7K | -11.6% |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗